Medi Caps Ltd Stock Price Today (NSE: MEDICAPQ)
Fundamental Score
Medi Caps Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Medi Caps Ltd share price today is ₹30.11, up +2.90% on NSE/BSE as of 22 June 2026. Medi Caps Ltd (MEDICAPQ) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹41.96 (Cr). The 52-week high for MEDICAPQ share price is ₹46.99 and the 52-week low is ₹21.00. The company has a Return on Equity (ROE) of -1.94% and a debt-to-equity ratio of 0.00.
Medi Caps Ltd Share Price Chart — NSE/BSE Historical Performance
Medi Caps Ltd share price chart: 6.46% return over the past month. 52-week high ₹46.99, 52-week low ₹21.00.
Medi Caps Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹29.12 | ₹31.65 | ₹29.10 | ₹30.11 | 4.15K (Cr) | |
| ₹28.50 | ₹33.00 | ₹28.50 | ₹29.26 | 1.52K (Cr) | |
| ₹34.95 | ₹34.95 | ₹28.20 | ₹28.56 | 6.08K (Cr) | |
| ₹28.98 | ₹33.00 | ₹27.50 | ₹31.47 | 10.45K (Cr) | |
| ₹26.00 | ₹28.00 | ₹26.00 | ₹28.00 | 3.73K (Cr) | |
| ₹26.71 | ₹26.99 | ₹26.06 | ₹26.36 | 2.15K (Cr) | |
| ₹26.16 | ₹26.79 | ₹26.10 | ₹26.19 | 8.94K (Cr) | |
| ₹28.00 | ₹28.07 | ₹26.36 | ₹26.63 | 2.61K (Cr) | |
| ₹27.06 | ₹28.50 | ₹26.06 | ₹27.01 | 2.90K (Cr) | |
| ₹26.94 | ₹28.38 | ₹26.94 | ₹27.09 | 1.29K (Cr) |
Medi Caps Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹28.50 | ₹33.00 | ₹28.50 | ₹30.11 | +5.65% | |
| ₹26.01 | ₹36.00 | ₹26.00 | ₹28.56 | +9.80% | |
| ₹22.66 | ₹31.97 | ₹22.66 | ₹28.12 | +24.10% | |
| ₹24.61 | ₹28.62 | ₹21.00 | ₹23.20 | -5.73% | |
| ₹26.56 | ₹27.45 | ₹21.02 | ₹24.61 | -7.34% | |
| ₹31.20 | ₹36.19 | ₹25.70 | ₹26.90 | -13.78% | |
| ₹34.00 | ₹35.99 | ₹28.13 | ₹31.23 | -8.15% | |
| ₹38.22 | ₹42.99 | ₹32.31 | ₹33.51 | -12.32% | |
| ₹38.67 | ₹44.70 | ₹34.32 | ₹39.00 | +0.85% | |
| ₹40.04 | ₹42.25 | ₹35.70 | ₹37.13 | -7.27% | |
| ₹42.53 | ₹46.98 | ₹37.20 | ₹40.04 | -5.85% | |
| ₹42.70 | ₹46.99 | ₹41.00 | ₹43.12 | +0.98% |
AI Research Briefing
Powered by Gemini · 2026-04-17
Medi Caps is a micro-cap gamble with brutal financials; only touch it if you're betting on a high-risk, high-reward turnaround.
WHAT'S HAPPENING NOW (last 2-4 weeks)
No major catalysts found after live search. Medi Caps Ltd. confirmed it is not classified as a 'Large Corporate' as of March 31, 2026, due to zero outstanding borrowing. The company also announced a special window for the transfer and dematerialization of physical securities.
CORE STORY (THE REAL GAME)
Medi Caps is a micro-cap play straddling pharma and real estate, but primarily a real estate play. The market is likely viewing it as a turnaround story, hoping for a recovery in either or both of its divisions.
- Real estate division showing signs of recovery
- Zero debt simplifies regulatory compliance
- India Pharma 2026 highlighting policy push and innovation
- Significant real estate deal
- Pharma division achieving profitability
- Acquisition by a larger player
- Micro/SME cap implies liquidity risk
- Negative profitability metrics
- Declining sales and profit growth
No significant FII/DII activity. Promoter holding stable at 50.77%.
Indian pharmaceutical industry is undergoing a transition phase with increased investment in API and KSM.
Profit not converting to cash. Free Cash Flow 5Y is ₹21.38 Cr, but recent performance is weak.
3-6 month thesis: Watch for real estate sales momentum and any signs of pharma recovery. Avoid if losses continue.
Primary Thesis Risk
Inability to achieve profitability in either real estate or pharma division will lead to capital erosion.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Medi Caps Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Medi Caps Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of MEDICAPQ across key market metrics for learning purposes.
Positive Indicators
3 factors identified
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Balanced Promoter Holding (50.77%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
8 factors identified
Below-Average Return on Equity (-1.94%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-2.12%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Profit Decline Concern (-687.10%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-75.63%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Limited Growth History (-9.96% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Interest Coverage (-196.33x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Limited Institutional Interest (FII+DII: 0.03%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Medi Caps Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Medi Caps Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Medi Caps LtdMedi Caps Ltd...Selected✓ MEDICAPQ • 523144 | 20.6/100 | ₹30.11₹30 | ₹41.96₹41.96 | — — | -1.94%Poor -1.94% Poor | -2.12%Poor -2.12% Poor | 0.00Excellent 0.0 Excellent | 10.20%Good 10.20% Good | -9.96%Poor -9.96% Poor | 0.00% |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 65.2/100 | ₹1882.30₹1882 | ₹433738.68₹433738.68 | 37.57Average 37.6 Average | 16.86%Good 16.86% Good | 20.21%Excellent 20.21% Excellent | 0.07Excellent 0.1 Excellent | 23.78%Excellent 23.78% Excellent | 9.87%Good 9.87% Good | 0.89% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 67.9/100 | ₹6797.50₹6798 | ₹170445.88₹170445.88 | 68.59Average 68.6 Average | 15.35%Good 15.35% Good | 20.44%Excellent 20.44% Excellent | 0.01Excellent 0.0 Excellent | 10.41%Good 10.41% Good | 11.65%Good 11.65% Good | 0.47% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 65.3/100 | ₹4460.10₹4460 | ₹126430.62₹126430.62 | 58.36Average 58.4 Average | 26.52%Excellent 26.52% Excellent | 27.05%Excellent 27.05% Excellent | 0.33Excellent 0.3 Excellent | 13.84%Good 13.84% Good | 7.72%Good 7.72% Good | 0.86% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 59/100 | ₹1418.20₹1418 | ₹123059.76₹123059.76 | 22.62Average 22.6 Average | 17.77%Good 17.77% Good | 22.72%Excellent 22.72% Excellent | 0.01Excellent 0.0 Excellent | 28.68%Excellent 28.68% Excellent | 9.97%Good 9.97% Good | 0.85% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 59.2/100 | ₹1335.20₹1335 | ₹105224.96₹105224.96 | 18.23Average 18.2 Average | 17.96%Good 17.96% Good | 22.69%Excellent 22.69% Excellent | 0.16Excellent 0.2 Excellent | 22.28%Excellent 22.28% Excellent | 13.26%Good 13.26% Good | 0.63% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 66.7/100 | ₹2287.40₹2287 | ₹95148.15₹95148.15 | 22.00Average 22.0 Average | 20.62%Excellent 20.62% Excellent | 21.30%Excellent 21.30% Excellent | 0.32Excellent 0.3 Excellent | 54.88%Excellent 54.88% Excellent | 8.11%Good 8.11% Good | 0.58% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 68.7/100 | ₹956.95₹957 | ₹94253.78₹94253.78 | 18.74Average 18.7 Average | 21.21%Excellent 21.21% Excellent | 24.31%Excellent 24.31% Excellent | 0.38Excellent 0.4 Excellent | 25.92%Excellent 25.92% Excellent | 10.27%Good 10.27% Good | 1.17% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 50.6/100 | ₹2492.60₹2493 | ₹92012.53₹92012.53 | 52.62Average 52.6 Average | 14.68%Average 14.68% Average | 15.98%Good 15.98% Good | 0.55Good 0.6 Good | 11.73%Good 11.73% Good | 15.79%Excellent 15.79% Excellent | 0.04% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 28.8/100 | ₹1435.90₹1436 | ₹70798.69₹70798.69 | 20.69Average 20.7 Average | 11.08%Average 11.08% Average | 14.18%Average 14.18% Average | 0.22Excellent 0.2 Excellent | 3.87%Average 3.87% Average | 6.55%Good 6.55% Good | 0.33% |
Alkem Laboratories LtdAlkem Laborator... ALKEM • 539523 | 59.5/100 | ₹5451.50₹5452 | ₹67075.29₹67075.29 | 28.54Average 28.5 Average | 19.39%Good 19.39% Good | 20.38%Excellent 20.38% Excellent | 0.18Excellent 0.2 Excellent | 13.93%Good 13.93% Good | 9.21%Good 9.21% Good | 0.80% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price433738.68 Cr
- Divis Laboratories Ltd share price170445.88 Cr
- Torrent Pharmaceuticals Ltd share price126430.62 Cr
- Cipla Ltd share price123059.76 Cr
- Dr Reddys Laboratories Ltd share price105224.96 Cr
Medi Caps Ltd Quarterly Performance
Latest quarterly metrics for MEDICAPQ — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-75.63%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-687.10%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
-9.96%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
10.20%
Compounded annual net profit growth over 5 years
Medi Caps Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for MEDICAPQ — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Medi Caps Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Medi Caps Ltd (MEDICAPQ) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Medi Caps Ltd
About MEDICAPQ (Medi Caps Ltd)
Medi Caps Ltd is a dynamic pharmaceutical company dedicated to advancing healthcare through innovative drug development and manufacturing. With a focus on providing high-quality, a...ffordable medicines, Medi Caps is committed to improving patient outcomes across a range of therapeutic areas. The company’s state-of-the-art facilities adhere to the strictest international regulatory standards, ensuring the safety and efficacy of its products. Medi Caps is actively involved in research and development, constantly seeking new and improved formulations to address unmet medical needs. Their dedication extends beyond product development; they are focused on building strong partnerships with healthcare professionals and distributors to ensure their medications are accessible to those who need them most. Medi Caps operates with a deep commitment to ethical business practices and environmental sustainability. The company strives to minimize its environmental footprint by implementing eco-friendly manufacturing processes and promoting responsible waste management. Furthermore, Medi Caps actively engages with local communities through various initiatives aimed at improving health and well-being. The company believes in fostering a culture of innovation and collaboration, empowering its employees to contribute their expertise and passion to the pursuit of pharmaceutical excellence. They have invested significantly in training and development programs to nurture talent and build a highly skilled workforce capable of driving future growth. Medi Caps Ltd is strategically positioned for continued growth and success in the evolving pharmaceutical landscape. By focusing on innovation, quality, and accessibility, the company is poised to expand its product portfolio and reach new markets. Medi Caps continues to build its brand reputation as a trusted provider of high-quality medications, and is focused on building long-term value for its stakeholders. With a strong leadership team and a dedicated workforce, Medi Caps is well-equipped to meet the challenges and opportunities of the pharmaceutical industry, remaining committed to its mission of improving global health and well-being.
Company Details
Key Leadership
Corporate Events
MEDICAPQ Share Price: Frequently Asked Questions
What is the current share price of Medi Caps Ltd?
Medi Caps Ltd (MEDICAPQ) trades at ₹30.11 on NSE and BSE. Market cap ₹41.96 (Cr). Educational data only.
What is the P/E ratio of Medi Caps Ltd?
Medi Caps Ltd has a P/E of N/Ax vs industry average 31.77x.
What is the Bull Run score for Medi Caps Ltd?
Medi Caps Ltd has a Bull Run score of 20.6/100 based on 25+ financial parameters.
Does Medi Caps Ltd pay dividends?
Medi Caps Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Medi Caps Ltd?
Medi Caps Ltd has ROE of -1.94%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Medi Caps Ltd?
Medi Caps Ltd has debt-to-equity of 0.00.
Is Medi Caps Ltd a good investment?
Bull Run gives Medi Caps Ltd a score of 20.6/100. This is not investment advice — consult a SEBI-registered advisor.